# Akriveia Therapeutics, LLC: Form D filings

Akriveia Therapeutics, LLC, a biotechnology company in Skillman, NJ, filed 2 Form D notices with the SEC between 2016 and 2018. The latest, on January 31, 2018, reports $3 million sold of a $22.5 million offering to 1 investor.

Find out what Akriveia Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Akriveia%20Therapeutics%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Akriveia%20Therapeutics%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fakriveia-therapeutics-llc-1676950)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Akriveia%20Therapeutics%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Akriveia%20Therapeutics%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fakriveia-therapeutics-llc-1676950)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 23 SOUTHERN HILLS DRIVE, Skillman, NJ, 08558
- Phone: (609) 560-0927
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Year incorporated: 2016
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1676950

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 31, 2018 | New notice | $22,500,000 | $3,000,000 | $19,500,000 | 1 | Jan 23, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1676950/000167695018000001/0001676950-18-000001-index.htm) |
| Jun 15, 2016 | New notice | $7,500,000 | $4,500,000 | $3,000,000 | 1 | May 25, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1676950/000167695016000001/0001676950-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Benjamin Auspitz | Director |  |
| Thomas Beck | Director |  |
| Michael Gladstone | Director |  |
| Simon Tomlinson | Executive Officer, Director |  |
| David Grayzel | Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Jan 29, 2018](https://specstream.ai/data/form-d/week/2018-01-29) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Akriveia Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).